GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XBUL:SRT3) » Definitions » Cyclically Adjusted Revenue per Share

Sartorius AG (XBUL:SRT3) Cyclically Adjusted Revenue per Share : лв63.80 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Sartorius AG Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Sartorius AG's adjusted revenue per share for the three months ended in Mar. 2025 was лв24.273. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is лв63.80 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Sartorius AG's average Cyclically Adjusted Revenue Growth Rate was 14.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 17.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 18.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Sartorius AG was 20.20% per year. The lowest was 10.20% per year. And the median was 17.60% per year.

As of today (2025-05-13), Sartorius AG's current stock price is лв179.45. Sartorius AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was лв63.80. Sartorius AG's Cyclically Adjusted PS Ratio of today is 2.81.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sartorius AG was 33.28. The lowest was 3.52. And the median was 8.45.


Sartorius AG Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Sartorius AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Cyclically Adjusted Revenue per Share Chart

Sartorius AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 61.27

Sartorius AG Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 47.23 49.48 61.27 63.80

Competitive Comparison of Sartorius AG's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Sartorius AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Cyclically Adjusted PS Ratio falls into.


;
;

Sartorius AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sartorius AG's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=24.273/127.7792*127.7792
=24.273

Current CPI (Mar. 2025) = 127.7792.

Sartorius AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 8.093 100.417 10.298
201509 8.616 100.417 10.964
201512 8.050 99.717 10.315
201603 8.531 100.017 10.899
201606 25.734 100.717 32.649
201609 9.738 101.017 12.318
201612 9.207 101.217 11.623
201703 9.236 101.417 11.637
201706 10.268 102.117 12.848
201709 10.500 102.717 13.062
201712 11.456 102.617 14.265
201803 11.324 102.917 14.060
201806 11.871 104.017 14.583
201809 11.916 104.718 14.540
201812 12.264 104.217 15.037
201903 12.620 104.217 15.473
201906 13.347 105.718 16.132
201909 13.079 106.018 15.764
201912 13.572 105.818 16.389
202003 14.489 105.718 17.513
202006 16.004 106.618 19.180
202009 18.949 105.818 22.882
202012 20.613 105.518 24.962
202103 24.071 107.518 28.607
202106 25.940 108.486 30.553
202109 27.105 109.435 31.649
202112 26.836 110.384 31.065
202203 28.999 113.968 32.513
202206 28.150 115.760 31.073
202209 26.801 118.818 28.822
202212 28.964 119.345 31.011
202303 24.887 122.402 25.980
202306 23.236 123.140 24.111
202309 22.280 124.195 22.923
202312 23.864 123.773 24.636
202403 22.543 125.038 23.037
202406 23.220 125.882 23.570
202409 22.477 126.198 22.759
202412 48.870 127.041 49.154
202503 24.273 127.779 24.273

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Sartorius AG  (XBUL:SRT3) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sartorius AG's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=179.45/63.80
=2.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sartorius AG was 33.28. The lowest was 3.52. And the median was 8.45.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Sartorius AG Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG Business Description

Industry
Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Sartorius AG Headlines

No Headlines